BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22298777)

  • 1. Characterization of heparin-binding site of tissue transglutaminase: its importance in cell surface targeting, matrix deposition, and cell signaling.
    Wang Z; Collighan RJ; Pytel K; Rathbone DL; Li X; Griffin M
    J Biol Chem; 2012 Apr; 287(16):13063-83. PubMed ID: 22298777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RGD-independent cell adhesion via a tissue transglutaminase-fibronectin matrix promotes fibronectin fibril deposition and requires syndecan-4/2 α5β1 integrin co-signaling.
    Wang Z; Collighan RJ; Gross SR; Danen EH; Orend G; Telci D; Griffin M
    J Biol Chem; 2010 Dec; 285(51):40212-29. PubMed ID: 20929862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2.
    Scarpellini A; Germack R; Lortat-Jacob H; Muramatsu T; Billett E; Johnson T; Verderio EA
    J Biol Chem; 2009 Jul; 284(27):18411-23. PubMed ID: 19398782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transglutaminase-2 interaction with heparin: identification of a heparin binding site that regulates cell adhesion to fibronectin-transglutaminase-2 matrix.
    Lortat-Jacob H; Burhan I; Scarpellini A; Thomas A; Imberty A; Vivès RR; Johnson T; Gutierrez A; Verderio EA
    J Biol Chem; 2012 May; 287(22):18005-17. PubMed ID: 22442151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between transglutaminases and heparan sulphate in progressive renal scarring.
    Burhan I; Furini G; Lortat-Jacob H; Atobatele AG; Scarpellini A; Schroeder N; Atkinson J; Maamra M; Nutter FH; Watson P; Vinciguerra M; Johnson TS; Verderio EA
    Sci Rep; 2016 Oct; 6():31343. PubMed ID: 27694984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the heparan sulphate-dependent externalisation of transglutaminase-2 (TG2) in glucose-stimulated proximal-like tubular epithelial cells.
    Furini G; Burhan I; Huang L; Savoca MP; Atobatele A; Johnson T; Verderio EAM
    Anal Biochem; 2020 Aug; 603():113628. PubMed ID: 32074489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies from patients with celiac disease inhibit transglutaminase 2 binding to heparin/heparan sulfate and interfere with intestinal epithelial cell adhesion.
    Teesalu K; Panarina M; Uibo O; Uibo R; Utt M
    Amino Acids; 2012 Feb; 42(2-3):1055-64. PubMed ID: 21847613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibronectin-tissue transglutaminase matrix rescues RGD-impaired cell adhesion through syndecan-4 and beta1 integrin co-signaling.
    Telci D; Wang Z; Li X; Verderio EA; Humphries MJ; Baccarini M; Basaga H; Griffin M
    J Biol Chem; 2008 Jul; 283(30):20937-47. PubMed ID: 18499669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of syndecan-4 and syndecan -2 in osteoblast cell adhesion and survival mediated by a tissue transglutaminase-fibronectin complex.
    Wang Z; Telci D; Griffin M
    Exp Cell Res; 2011 Feb; 317(3):367-81. PubMed ID: 21036168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transglutaminase 2 interactions with extracellular matrix proteins as probed with celiac disease autoantibodies.
    Cardoso I; Stamnaes J; Andersen JT; Melino G; Iversen R; Sollid LM
    FEBS J; 2015 Jun; 282(11):2063-75. PubMed ID: 25808416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells.
    Soluri MF; Boccafoschi F; Cotella D; Moro L; Forestieri G; Autiero I; Cavallo L; Oliva R; Griffin M; Wang Z; Santoro C; Sblattero D
    FASEB J; 2019 Feb; 33(2):2327-2342. PubMed ID: 30285580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase 2 strongly binds to an extracellular matrix component other than fibronectin via its second C-terminal beta-barrel domain.
    Stamnaes J; Cardoso I; Iversen R; Sollid LM
    FEBS J; 2016 Nov; 283(21):3994-4010. PubMed ID: 27685605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular TG2: emerging functions and regulation.
    Belkin AM
    FEBS J; 2011 Dec; 278(24):4704-16. PubMed ID: 21902810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses.
    Stephens P; Grenard P; Aeschlimann P; Langley M; Blain E; Errington R; Kipling D; Thomas D; Aeschlimann D
    J Cell Sci; 2004 Jul; 117(Pt 15):3389-403. PubMed ID: 15199098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A crucial sequence for transglutaminase type 2 extracellular trafficking in renal tubular epithelial cells lies in its N-terminal beta-sandwich domain.
    Chou CY; Streets AJ; Watson PF; Huang L; Verderio EA; Johnson TS
    J Biol Chem; 2011 Aug; 286(31):27825-35. PubMed ID: 21652693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatan sulfate is a player in the transglutaminase 2 interaction network.
    Wisowski G; Koźma EM; Bielecki T; Pudełko A; Olczyk K
    PLoS One; 2017; 12(2):e0172263. PubMed ID: 28199387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocyte-derived tissue transglutaminase interacts with fibronectin: a role in astrocyte adhesion and migration?
    van Strien ME; Brevé JJ; Fratantoni S; Schreurs MW; Bol JG; Jongenelen CA; Drukarch B; van Dam AM
    PLoS One; 2011; 6(9):e25037. PubMed ID: 21949843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting the interaction between transglutaminase 2 and fibronectin.
    Cardoso I; Østerlund EC; Stamnaes J; Iversen R; Andersen JT; Jørgensen TJ; Sollid LM
    Amino Acids; 2017 Mar; 49(3):489-500. PubMed ID: 27394141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
    Kotsakis P; Wang Z; Collighan RJ; Griffin M
    Amino Acids; 2011 Oct; 41(4):909-21. PubMed ID: 21046178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions.
    Badarau E; Wang Z; Rathbone DL; Costanzi A; Thibault T; Murdoch CE; El Alaoui S; Bartkeviciute M; Griffin M
    Chem Biol; 2015 Oct; 22(10):1347-61. PubMed ID: 26456735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.